Table 1.
Summary of natural compounds and activities related to the treatment of amyotrophic lateral sclerosis (ALS).
| Class of Pharmacological Activity and Compound Name | Evidence of Pharmacological Activity Related to ALS |
|---|---|
| Oxidative Stress | |
| Curcumin and Dimethoxy Curcumin (DMC) | Activate Nrf2; protect cells against stress through the removal of free radicals and detoxication; eliminate the excitability induced by TDP-43. Inhibits DTT-induced SOD1 fibrillation and favors the formation of smaller and disordered SOD1 aggregates, reduction in SOD1-mediated toxicity; assessed in In vivo and in vitro studies, with clinical trials. |
| Resveratrol | Up-regulating SIRT1 expression in the mutant SOD1G93A-bearing motor neuron-like culture model of ALS, improving the cell viability and ATP levels and preventing cell apoptosis. |
| Epigallocatechin gallate (EGCG) | Inhibits most types of the apoptotic cell by up-regulation of Bcl-2, downregulating the Bax gene; protecting against lipid peroxidation; preventing OS-induced death of mutant SOD1; upregulating PI3K/Akt and GSK-3 pathways in G93A mutant cells; assess in In vivo and in vitro studies. |
| 7,8-dihydroxyflavone (7,8-DHF) | Enhanced neuromuscular transmission via TrkB activation in diaphragm muscle preserves spinal motor neuron count, and dendritic spines; assessed in In vitro studies. |
| Quercetin | Prevents aluminum-induced translocation of cytochrome c, upregulates Bcl-2, down-regulates Bax, p53, and caspase-3 activation, and reduces DNA fragmentation; assess in In vivo and in vitro studies. |
| Firestin | Increased the expression of phosphorylated ERK, increased the expression of antioxidant factors, and reduce the levels of mutant and wild-type SOD1. |
| Ampelopsin | Prevented H2O2-induced p38 activation; Upregulation of HO-1 due to the activation of ERK and Akt signaling pathways; assessed in In vitro and in vivo studies. |
| Vitamin E | Using it as an adjuvant treatment with riluzole allowed us to verify changes in the levels of biochemical markers for oxidative stress; assessed in In vivo studies. |
| Astragaloside IV | Attenuate the H2O2-induced loss; Decrease apoptosis and attenuate ROS overproduction; Protects microglia from lipopolysaccharide-evoked death and down-regulated the release of pro-inflammatory mediators IL-1β, IL-6, TNF-α, and NO, and the expression of TLR4, MyD88, and NF-κB. |
| Madecassoside | Reduce neuronal damage caused by OS and inhibit apoptosis; reduce neurotoxicity, cognitive impairments, and the production of inflammatory cytokine agents (IL-1β, TNF-α, and IL-6 by activation of Nrf2 signaling); assessed in in vitro and in vivo studies. |
| Morronoside | Inhibitory effects on ROS formation and activation of caspase-3 and 9, up-regulate Bcl-2 in SH-SY5Y cells of a model of H2O2-induced toxicity. Reduce the intracellular accumulation of Ca2+ and decrease the mitochondrial membrane potential caused by the addition of H2O2. |
| Picroside-II | Increase in neurite outgrowth in PC-12 cells. Enable an increase in cell viability and a reduction in glutamate-induced ROS; assess in In vitro and In vivo studies. |
| Dially Trissufide | DATS treatment activated HO-1. Cause activation of Nrf2 and Nrf2 target gene in rat spinal cord, protected motor neurons against glutamate-induced excitotoxicity. Induces neuronal autophagy and lysosomal clearance of TDP-43 and C-terminal TDP-43 fragments. |
| Neuroinflammation | |
| Celastrol | Down-regulates the expression of TNF-α and iNOS and the immunoreactivity of CD40 and GFAP; Inhibition of excessive production of NO, TNF-α, and IL-1β induced by lipopolysaccharide in BV-2 cells; attenuates cadmium-induced neuronal apoptosis via the calcium-dependent Akt/mTOR pathway. |
| Paeonol | Prevent cell death and mitochondrial injury; Reduces caspase-3 and p-ERK activity; Attenuates the overexpression of NO-synthase and cyclooxygenase 2; Reduced the production of ROS-upregulated HO-1. |
| Obovatrol | Inhibition of NO production, microglial expression of pro-inflammatory cytokines, multiple signaling pathways (NF-κB, STAT1, and MAPK); Protect neurons from microglial toxicity; inhibit neuroinflammation; assess in In vivo studies. |
| Isorhynchophylline | Attenuates proinflammatory cytokines production such as TNF-α and IL-1β as well as NO in mouse N9 microglial cells; Suppression of iNOS protein level, phosphorylation of ERK and p38 MAPKs, and degradation of IκBα. |
| Wogonin | Diminishes lipopolysaccharide-induced TNF-α, IL-1β, and NO production in a dose-dependent manner; Promotes the reduction in microglial cytotoxicity in PC-12 cells; Protective against experimental brain injury (in vivo). |
| Ginkgolide A | Inhibits NO production in lipopolysaccharide-stimulated microglia; Modulation of neuroinflammation caused by neurodegenerative processes. |
| Excitatory Amino Acid Toxicity | |
| β-asarone | Neuroprotective action against NMDA or glutamate-induced excitotoxicity by blocking NMDA receptor function; Promotes a decrease in LDH leakage. |
| Catalpol | Suppress the down-regulation of Bcl-2 and up-regulation of Bax; Release mitochondrial cytochrome c to the cytosol; Attenuates the activation of caspase-3 and PARP cleavage and protects against apoptosis. |
| Huperzine-A | Reduces glutamate-mediated Ca2+ signaling; Attenuates excitatory amino acid toxicity; Modulates Ca2+ levels through the Cdk5 activation pathway. |
| Selaginellin | Acts against glutamate-induced toxicity in PC-12 cells, reducing ROS levels and regulating the Klotho gene. |
| Cryptotanshinone | Acts on glutamate-induced toxicity, protecting primary cortical neurons from neurotoxicity through activation of the phosphoinositide 3-kinase/Akt. |
| Ferulic Acid | Activated caspase-3 protein expression and PARP cleavage and inhibited the upregulation of glutamate-induced μ-calpain protein level; Inhibition of glutamate-induced reduction in Bcl-2 expression. |
| Anti-calcium Cytotoxicity | |
| Paeoniflorin | Increases cell viability, inhibits apoptosis, decreases intracellular ROS and malondialdehyde levels, and increases SOD1 activity. |
| Gastrodin | Reduces intracellular Ca2+ level via voltage-gated Ca2+ channels. |
| Muscone | Inhibits Glu-induced apoptosis in PC-12 cells by a mechanism related to inhibition of intracellular Ca2+ overload and maintenance of mitochondrial membrane potential. |
| Ligustrazine | Inhibits L-type calcium current in SH-SY5Y human neuroblastoma. |